The new iridium complex selectively targets cancer stem cells and has potential to induce immunogenic cell death in cancer cells.
No takes yet. Share an insight, caveat, or question.
Vigueras et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: